Compare Becton Dickinson and Co (BDX) vs Crocs, Inc. (CROX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Crocs, Inc. — how do they compare? Becton Dickinson and Co trades at $154.29 (market cap $42.39B), while Crocs, Inc. trades at $131.17 (market cap $6.48B). The key difference: Becton Dickinson and Co is far larger — about 6.5× Crocs, Inc.'s market cap, and Becton Dickinson and Co pays a 2.73% dividend while Crocs, Inc. pays none. Which is the better fit depends on your goals.
| BDX | CROX | |
|---|---|---|
Market Cap | $42.39B | $6.48B |
Sector | Health | Consumer Staples |
52-Week High | $185.39 | $132.78 |
52-Week Low | $135.49 | $73.39 |
Enterprise Value | $58.85B | $8.08B |
Dividend Yield | 2.73% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Crocs, Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company include Americas, Asia pacific, and EMEA.
Read more on CROX →
